| Product Code: ETC5821257 | Publication Date: Nov 2023 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, Austria`s import trend for the biologics market experienced a decline, with a growth rate of -3.3% compared to the previous year. The compound annual growth rate (CAGR) for 2020-2024 stood at -10.36%. This negative import momentum may be attributed to shifts in demand dynamics or evolving trade policies impacting market stability.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Biologics Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Biologics Market Revenues & Volume, 2022 & 2032F |
3.3 Austria Biologics Market - Industry Life Cycle |
3.4 Austria Biologics Market - Porter's Five Forces |
3.5 Austria Biologics Market Revenues & Volume Share, By Source, 2022 & 2032F |
3.6 Austria Biologics Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.7 Austria Biologics Market Revenues & Volume Share, By Disease? Category, 2022 & 2032F |
3.8 Austria Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2022 & 2032F |
4 Austria Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Austria |
4.2.2 Growing adoption of biologics due to their targeted approach and efficacy |
4.2.3 Rising investments in research and development for biologics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of biologics |
4.3.2 High cost associated with biologics limiting affordability and accessibility |
5 Austria Biologics Market Trends |
6 Austria Biologics Market Segmentations |
6.1 Austria Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Austria Biologics Market Revenues & Volume, By Microbial, 2022-2032F |
6.1.3 Austria Biologics Market Revenues & Volume, By Mammalian, 2022-2032F |
6.1.4 Austria Biologics Market Revenues & Volume, By Others, 2022-2032F |
6.2 Austria Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Austria Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2022-2032F |
6.2.3 Austria Biologics Market Revenues & Volume, By Vaccines, 2022-2032F |
6.2.4 Austria Biologics Market Revenues & Volume, By Recombinant Proteins, 2022-2032F |
6.2.5 Austria Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2022-2032F |
6.2.6 Austria Biologics Market Revenues & Volume, By Others, 2022-2032F |
6.3 Austria Biologics Market, By Disease? Category |
6.3.1 Overview and Analysis |
6.3.2 Austria Biologics Market Revenues & Volume, By Oncology, 2022-2032F |
6.3.3 Austria Biologics Market Revenues & Volume, By Infectious Diseases, 2022-2032F |
6.3.4 Austria Biologics Market Revenues & Volume, By Immunological Disorders, 2022-2032F |
6.3.5 Austria Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2022-2032F |
6.3.6 Austria Biologics Market Revenues & Volume, By Hematological Disorders, 2022-2032F |
6.3.7 Austria Biologics Market Revenues & Volume, By Others, 2022-2032F |
6.4 Austria Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Austria Biologics Market Revenues & Volume, By Outsourced, 2022-2032F |
6.4.3 Austria Biologics Market Revenues & Volume, By In-house, 2022-2032F |
7 Austria Biologics Market Import-Export Trade Statistics |
7.1 Austria Biologics Market Export to Major Countries |
7.2 Austria Biologics Market Imports from Major Countries |
8 Austria Biologics Market Key Performance Indicators |
8.1 Average time-to-market for new biologics in Austria |
8.2 Number of clinical trials for biologics conducted in Austria |
8.3 Rate of adoption of biosimilars in the Austrian market |
9 Austria Biologics Market - Opportunity Assessment |
9.1 Austria Biologics Market Opportunity Assessment, By Source, 2022 & 2032F |
9.2 Austria Biologics Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.3 Austria Biologics Market Opportunity Assessment, By Disease? Category, 2022 & 2032F |
9.4 Austria Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2022 & 2032F |
10 Austria Biologics Market - Competitive Landscape |
10.1 Austria Biologics Market Revenue Share, By Companies, 2025 |
10.2 Austria Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here